Canadian Journal of Infectious Diseases and Medical Microbiology

Table of Contents: 1992

  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 510914

BRM Immunotherapy of Orthotopically Implanted Murine Bladder Tumours: Treatment Response by Monitoring MRI

Salam A Kadhim | Joseph L Chin | ... | Stephen J Karlik
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 652358
  • - Case Report

De Novo Subgaleal Abscess

JP Schaefer | LJ Clein | JM Conly
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 917546

AM3, an Oral BRM: Protective Agent against Iatrogenic Bone-Marrow and Liver Damage in Breast Cancer Patients under Conventional Adjuvant Radiochemotherapy

Vicente G Villarrubia | Paula Marquez | ... | Guillermo J Sada
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 342127

Continuous Indomethacin and Ranitidine with Interleukin-2 in Advanced Renal Carcinoma and Melanoma: A Preliminary Report

Wilson C Mertens | Vivien HC Bramwell | ... | Walter Romano
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 754560

Interferons: Antiangiogenesis Agents (A Reasonable Theory)

Joseph G Sinkovics
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 234936

Preclinical Evaluation of a Bone-Marrow Autograft Culture Procedure for Generating Lymphokine-Activated Killer Cells in Vitro

Hans-Georg Klingemann | Heather Deal | ... | Connie J Eaves
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 460394

Interferon-gamma: A Potent Antiviral Agent Targeting Macrophages Infected with LP-BM5 Murine Leukemia Virus, the Causative Agent of 'AIDS' in Mice

Jens J Kort | Julie L Eiseman
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 875050

Involvement of Cytokines in the Pathogenesis of Hypersensitivity Pneumonitis: Evaluation of Immunotherapeutic Measures in a Mouse Model

Michel Denis | Marie Bédard | ... | Michel Laviolette
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 181709

Hypoxanthine Derivatives in Experimental Infections

Claudio De Simone | Edoardo Arrigoni Martelli | ... | Giorgio Tonietti
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 398178

Conjugation of Daunorubicin to Monoclonal Antihuman Sarcoma Antibody by a Novel Method

Michel Pagé | Denis Thibeault | ... | Marie-Josée Perron
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 591894

SDZ MRL 953, A Novel Synthetic Lipid a Analogue, Induces Tolerance to the Lethal Effects of Endotoxin and Enhances Nonspecific Immunity

Charles Lam | Eberhard Schütze | ... | Peter Stütz
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 342364

Adjuvants for a New Generation of Vaccines

Anthony C Allison | Noelene E Byars
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 710476
  • - Brief Report

Antibody to Hepatitis C Virus in Risk Groups in Canada

RK Chaudhary | Theresa Mo
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 480430

Potential Manipulations to Restore Aberrant Myelopoiesis: The Role of New Colony-Stimulating Factors and other Agents

James J Rusthoven
  • Canadian Journal of Infectious Diseases -
  • Special Issue
  • Volume 3
  • - Article ID 942680

Insights into Normal Myelopoiesis

Dennis G Osmond
Canadian Journal of Infectious Diseases and Medical Microbiology
 Journal metrics
See full report
Acceptance rate13%
Submission to final decision109 days
Acceptance to publication14 days
CiteScore3.700
Journal Citation Indicator0.480
Impact Factor2.8
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.